AMDS Hybrid Prosthesis
Acute DeBakey Type I Aortic Dissections (with malperfusion)
PivotalFDA HDE Approved; PMA under review. PERSEVERE Trial data presented.
Key Facts
Indication
Acute DeBakey Type I Aortic Dissections (with malperfusion)
Phase
Pivotal
Status
FDA HDE Approved; PMA under review. PERSEVERE Trial data presented.
Company
About Artivion
Artivion is a global medical device company dedicated to advancing the treatment of aortic diseases through a focused portfolio of surgical and endovascular solutions. The company's strategic acquisitions, including Ascyrus Medical and the On-X heart valve technology, have positioned it as a leader in aortic arch repair and mechanical heart valves. With over 1,600 employees worldwide, Artivion is driving patient-powered progress by collaborating with surgeons to address their most difficult challenges, supported by a robust clinical pipeline and recent regulatory milestones like the FDA HDE for its AMDS device.
View full company profile